PARAGON 28 INC (FNA)

FNA Stock Earnings: Paragon 28 Misses EPS, Beats Revenue for Q1 2024

FNA stock results show that Paragon 28 missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

FNA Stock Earnings: Paragon 28 Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Paragon 28 (NYSE:FNA) just reported results for the first quarter of 2024.Parag...

Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance

Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference

Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System

Paragon 28 Becomes Oversold (FNA)

Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance

Needham sees orthopedics market slowing; favors Enovis, Paragon 28

Needham says it expects growth in the orthopedic device market to slow later this year, but sees Enovis (ENOV) and Paragon 28 (FNA) as being able to beat the trend. Read more here.

Paragon 28 to Present at the CG 2024 Musculoskeletal Conference

Bullish Two Hundred Day Moving Average Cross - FNA

Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions

Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures

Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures

Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures

Paragon 28 reports preliminary Q4 revenue (NYSE:FNA)

Paragon 28 announces preliminary unaudited revenue for Q4 and full year 2023, surpassing market expectations with reported growth of 17% to 18% and 19% to...

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023

Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape

Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio

Paragon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple Offering

Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program

Paragon 28 says DaCosta buys 30.5K shares in the co through indirect ownership (NYSE:FNA)

Albert DaCosta purchases 30.5K shares in Paragon 28 at $8.51 per share, contributing to a 6.21% increase in the company's share value.

Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility

Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

Paragon 28 to Present at Upcoming Investor Conferences

Paragon 28 To Report Third Quarter Financial Results on November 7, 2023

Commit To Buy Paragon 28 At $10, Earn 10.4% Annualized Using Options

Paragon 28 Becomes Oversold (FNA)

Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System